Form 8-K - Current report:
SEC Accession No. 0001628280-16-016339
Filing Date
2016-05-13
Accepted
2016-05-13 16:47:06
Documents
3
Period of Report
2016-05-13
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K q120168k-earningsrelease.htm 8-K 37356
2 EXHIBIT 99.1 q12016-ex991earningsrelease.htm EX-99.1 229824
3 cumberlandpharmaimageaa01.jpg GRAPHIC 37721
  Complete submission text file 0001628280-16-016339.txt   320303
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 161649079
SIC: 2834 Pharmaceutical Preparations